Common Contracts
2 similar LBS-008 Research and Development Services Agreement contracts by Belite Bio, Inc
LBS-008 RESEARCH AND DEVELOPMENT SERVICES AGREEMENTLBS-008 Research and Development Services Agreement • April 5th, 2022 • Belite Bio, Inc • Pharmaceutical preparations
This Research and Development Services Agreement (this “Agreement”), effective as of July 1, 2021 (“Effective Date”), is entered into by and between Belite Bio, Inc, a Cayman corporation, with contact office located at 12F., No.68, Sec. 5, Zhongxiao E. Rd., Xinyi Dist., Taipei City 110, Taiwan (“Belite Inc”) and Lin BioScience, Inc., a Taiwan corporation, located at 12F., No.68, Sec. 5, Zhongxiao E. Rd., Xinyi Dist., Taipei City 110, Taiwan (“Lin Inc.”).
LBS-008 RESEARCH AND DEVELOPMENT SERVICES AGREEMENTLBS-008 Research and Development Services Agreement • January 21st, 2022 • Belite Bio, Inc • Pharmaceutical preparations
This Research and Development Services Agreement (this “Agreement”), effective as of July 1, 2021 (“Effective Date”), is entered into by and between Belite Bio, Inc, a Cayman corporation, with contact office located at 12F., No.68, Sec. 5, Zhongxiao E. Rd., Xinyi Dist., Taipei City 110, Taiwan (“Belite Inc”) and Lin BioScience, Inc., a Taiwan corporation, located at 12F., No.68, Sec. 5, Zhongxiao E. Rd., Xinyi Dist., Taipei City 110, Taiwan (“Lin Inc.”).
